KathleenLPostonMDMS(She/Her)

PubMed

• AI-based differential diagnosis of dementia etiologies on multimodal data.
  Chonghua Xue, Sahana S Kowshik, Diala Lteif, Shreyas Puducheri, Varuna H Jasodanand, Olivia T Zhou, Anika S Walia, Osman B Guney, J Diana Zhang, Serena T Pham, Artem K...> ;Medrxiv. 2024 Mar 26
• Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson's disease.
  Jarod Rutledge, Benoit Lehallier, Pardis Zarifkar, Patricia Moran Losada, Marian Shahid-Besanti, Dan Western, Priyanka Gorijala, Sephira Ryman, Maya Yutsis, Gayle K De...> ;Acta Neuropathologica. 2024 Mar 11
• Multiple biomarkers improve diagnostic accuracy across Lewy body and Alzheimer's disease spectra.
  Plastini, M., Abdelnour, C., Young, C., Wilson, E., Shahid-Besanti, M., Lamoureux, J., Kerchner, G., Andreasson, K., Montine, T., Henderson, V., Poston, K.> ;Annals of Clinical and Translational Neurology. 2024 Mar 4
• Post-translational modifications linked to preclinical Alzheimer's disease-related pathological and cognitive changes.
  Olamide Abiose, Jarod Rutledge, Patricia Moran-Losada, Michael E Belloy, Edward N Wilson, Zihuai He, Alexandra N Trelle, Divya Channappa, America Romero, Jennifer Park...> ;Alzheimer's & Dementia. 2024 Mar 1
• Impaired 24-h activity patterns are associated with an increased risk of Alzheimer's disease, Parkinson's disease, and cognitive decline.
  Winer, J., Lok, R., Weed, L., He, Z., Mormino, E., Zeitzer, J., Poston, K.> ;Alzheimer's Research & Therapy. 2024 Feb 14
• Speech patterns during memory recall relates to early tau burden across adulthood.
  Young, C., Smith, V., Karjadi, C., Grogan, S., Ang, T., Insel, P., Sumner, M., Au, R., Mormino, E., Henderson, V., Poston, K.> ;Alzheimer's & Dementia. 2024 Feb 13
• Evaluation of ATNFramework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease.
  Cousins, K., Irwin, D., Tropea, T., Rhodes, E., Phillips, J., Chen-Plotkin, A., Brumm, M., Coffey, C., Kang, J., Simuni, T., Foroud, T., Toga, A., Tanner, C., Kieburtz...> ;Neurology. 2024 Feb 1
• 13 citations
  A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research.
  Simuni, T., Chahine, L., Poston, K., Brumm, M., Buracchio, T., Campbell, M., Chowdhury, S., Coffey, C., Concha-Marambio, L., Dam, T., DiBiaso, P., Foroud, T., Frasier,...> ;The Lancet. Neurology. 2024 Feb 1
• Reliability of remote National Alzheimer's Coordinating Center Uniform Data Set data.
  Viktorija Smith, Kyan Younes, Kathleen L Poston, Elizabeth C Mormino, Christina B Young> ;Alzheimer's & Dementia. 2023 Nov 29
• Cerebellar Volume and Disease Staging in Parkinson's Disease: An ENIGMA-PD Study.
  Rebecca Kerestes, Max A Laansma, Conor Owens-Walton, Andrew Perry, Eva M van Heese, Sarah Al-Bachari, Tim J Anderson, Francesca Assogna, Ítalo K Aventurato, Tim D van ...> ;Movement Disorders. 2023 Dec 1
• 1 citations
  Quantitative estimate of cognitive resilience and its medical and genetic associations.
  Thanaphong Phongpreecha, Dana Godrich, Eloise Berson, Camilo Espinosa, Yeasul Kim, Brenna Cholerton, Alan L Chang, Samson Mataraso, Syed A Bukhari, Amalia Perna, Koya ...> ;Alzheimer's Research & Therapy. 2023 Nov 6
• An Explainable Geometric-Weighted Graph Attention Network for Identifying Functional Networks Associated with Gait Impairment.
  Favour Nerrise, Qingyu Zhao, Kathleen L Poston, Kilian M Pohl, Ehsan Adeli> ;Medical Image Computing and Computer-Assisted Intervention. 2023 Oct 1
• An Explainable Geometric-Weighted Graph Attention Network for Identifying Functional Networks Associated with Gait Impairment.
  Favour Nerrise, Qingyu Zhao, Kathleen L Poston, Kilian M Pohl, Ehsan Adeli> ;Arxiv. 2023 Jul 24
• 2 citations
  Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease Progression.
  Michael C Brumm, Andrew Siderowf, Tanya Simuni, Elliot Burghardt, Seung Ho Choi, Chelsea Caspell-Garcia, Lana M Chahine, Brit Mollenhauer, Tatiana Foroud, Douglas Gala...> ;Journal of Parkinson's Disease. 2023 Jan 1
• 1 citations
  Metrologically Traceable Quantification of 3 Apolipoprotein E Isoforms in Cerebrospinal Fluid.
  Huu-Hien Huynh, Kellie Kuch, Allen Orquillas, Katrina Forrest, Lili Barahona-Carrillo, Dirk Keene, Victor W Henderson, Anthony D Wagner, Kathleen L Poston, Thomas J Mo...> ;Clinical Chemistry. 2023 Jul 5
• 1 citations
  Impact of the Dopamine System on Long-Term Cognitive Impairment in Parkinson Disease: An Exploratory Study.
  Daniel Weintraub, Marina Picillo, Hyunkeun Ryan Cho, Chelsea Caspell-Garcia, Cornelis Blauwendraat, Ethan G Brown, Lana M Chahine, Christopher S Coffey, Roseanne D Dob...> ;Movement Disorders Clinical Practice. 2023 Jun 1
• 1 citations
  Reduced and Delayed Cerebrovascular Reactivity in Patients with Parkinson's Disease.
  Sephira G Ryman, Nicholas Shaff, Andrew Dodd, Stephanie Nitschke, Christopher Wertz, Kayla Julio, Gerson Suarez Cedeno, Amanda Deligtisch, Erik Erhardt, Henry Lin, And...> ;Movement Disorders. 2023 Jul 1
• 77 citations
  Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.
  Andrew Siderowf, Luis Concha-Marambio, David-Erick Lafontant, Carly M Farris, Yihua Ma, Paula A Urenia, Hieu Nguyen, Roy N Alcalay, Lana M Chahine, Tatiana Foroud, Dou...> ;The Lancet. Neurology. 2023 May 1
• 1 citations
  Episodic memory deficit in HIV infection: common phenotype with Parkinson's disease, different neural substrates.
  Rosemary Fama, Eva M Müller-Oehring, Taylor F Levine, Edith V Sullivan, Stephanie A Sassoon, Priya Asok, Helen M Brontë-Stewart, Kathleen L Poston, Kilian M Pohl, Adol...> ;Brain Structure & Function. 2023 May 1
• 5 citations
  Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022.
  Carla Abdelnour, Maria Camila Gonzalez, Lucy L Gibson, Kathleen L Poston, Clive G Ballard, Jeffrey L Cummings, Dag Aarsland> ;Neurology and Therapy. 2023 Jun 1
• 2 citations
  Computerized cognitive practice effects in relation to amyloid and tau in preclinical Alzheimer's disease: Results from a multi-site cohort.
  Christina B Young, Elizabeth C Mormino, Kathleen L Poston, Keith A Johnson, Dorene M Rentz, Reisa A Sperling, Kathryn V Papp> ;Alzheimer's & Dementia. 2023 Mar 20
• Cognitive Impairment in Neurodegenerative Movement Disorders.
  Carla Abdelnour, Kathleen L Poston> ;Seminars in Neurology. 2023 Feb 1
• 4 citations
  Synaptic Density and Glucose Consumption in Patients with Lewy Body Diseases: An [C]UCB-J and [F]FDG PET Study.
  Katrine B Andersen, Allan K Hansen, Anna Christina Schacht, Jacob Horsager, Hanne Gottrup, Henriette Klit, Erik H Danielsen, Kathleen L Poston, Nicola Pavese, David J ...> ;Movement Disorders. 2023 May 1
• 3 citations
  Listening session with the US Food and Drug Administration, Lewy Body Dementia Association, and an expert panel.
  Marwan N Sabbagh, Angela Taylor, Douglas Galasko, James E Galvin, Jennifer G Goldman, James B Leverenz, Kathleen L Poston, Bradley F Boeve, David J Irwin, Joseph F Quinn> ;Alzheimer's & Dementia. 2023 Feb 8
• 4 citations
  Prediction of neuropathologic lesions from clinical data.
  Thanaphong Phongpreecha, Brenna Cholerton, Syed Bukhari, Alan L Chang, Davide De Francesco, Melan Thuraiappah, Dana Godrich, Amalia Perna, Martin G Becker, Neal G Ravi...> ;Alzheimer's & Dementia. 2023 Jul 1
• Join now to see all